Finding heart amyloidosis on bone scans
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at past bone scans to find signs of a heart condition called amyloidosis, where abnormal proteins build up in the heart. It may help identify more people with this condition and improve future diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a bone scan (using a special radioactive tracer) for any reason.
- The scan showed unexpected heart uptake, which a specialist confirmed as significant.
- You are not under legal protection.
- You are okay with your medical data being used for research after being informed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This trial tests a faster heart-imaging method (bone scan) for people suspected of having transthyretin cardiac amyloidosis, a heart condition caused by abnormal protein deposits. The goal is to see if the faster scan gives the same clear images as the standard scan.
This trial is testing older adults with heart failure to see if a heart condition called cardiac amyloidosis (a buildup of abnormal protein in the heart) is present. If you are 80 or older, have been in the hospital for heart failure in the past year, and have a thickened heart wall, you may be able to join.
This study uses a special PET scan tracer to see how consistent the images are in people with heart amyloidosis (a buildup of abnormal protein in the heart) and in people without the condition. The goal is to improve diagnosis and monitoring.
This study tests different heart scans to find heart amyloidosis, a condition where abnormal proteins build up in the heart, in people who have certain warning signs. The goal is to see which test works best to help diagnose it faster.
This study collects information from adults who have been diagnosed with, or are being checked for, ATTR amyloidosis (a condition where abnormal protein builds up in the body) using a heart PYP scan. Your participation may help doctors better understand how these scans relate to diagnosis and follow-up over time.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.